Immediate Impact
5 hit
Citing Papers
Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations
2021 Hit
Molecular therapies for HCC: Looking outside the box
2020 Hit
Works of Kohei Ishikawa being referenced
A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEM) in patients (pts) with unresectable hepatocellular carcinoma (uHCC).
2018